Live Breaking News & Updates on பளபளப்பு ஆயுட்காலம் லிமிடெட்
Stay updated with breaking news from பளபளப்பு ஆயுட்காலம் லிமிடெட். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Breaking News: Glow LifeTech startet die Produktion von Cannabis-Präparaten auf MyCell®-Basis! wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.
Article content The results, announced on May 7, 2021, demonstrate the mechanism of action of ArtemiC™ is to reduce inflammation and suppress the cytokine storm 2 – believed to be the one of the leading causes of mortality in COVID-19 patients 3. The results show that ArtemiC™ decreases the markers of inflammation (IFN-g, IL-1a and TNF-a), in the bronchoalveolar lavage fluid (BALF) of mice in the animal model of cytokine storm related to COVID-19. The clinical and preclinical results to date support ArtemiC™ being effective for addressing cytokine overproduction which is found in different variants and mutations of COVID-19. “ArtemiC™ focuses on preventing and reducing the severity of the cytokine storm and hyper-inflammation induced by respiratory viruses, and since all current COVID-19 variants of concern may lead to a cytokine storm, the preclinical and clinical results support that ArtemiC™ should be effective on COVID-19 variants,” said Tom Gl ....
Glow LifeTech Announces Successful First Commercial Production of ArtemiC(TM) for Global Distributor and a Second Production Scaled to Meet Growing Global Demand streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Glow LifeTech Corp.: Glow LifeTech Announces Successful First Commercial Production of ArtemiC for Global Distributor and a Second Production Scaled to Meet Growing Global Demand Glow or the Company ), a biotech company focused on producing next-generation, science-backed natural ingredients, is pleased to announce the successful delivery of the first commercial production run of ArtemiC at its supply partner, Swiss PharmaCan AG ( SPC ) in April 2021 1, and a second production run worth nearly $1 million 2 CAD that is scaled to service the growing demand around the world. Glow ArtemiC https://orders.newsfilecorp.com/files/3920/82873 9c83b087946a5903 001full.jpg Building on the Company s recent application to Health Canada for its natural oral spray, ArtemiC, following its successful COVID-19 Phase II clinical trial (see Glow s release dated April 27, 2021), the Company s strategic focus is on expediting the launch of ArtemiC in Canada and beyond as ....
Relay Medical: Umsätze und Großaufträge pflastern den Weg zum Erfolg! wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.